OSW Stock Analysis: OneSpaWorld Holdings | NASDAQ
Leisure | NASDAQ, USA | Market Cap: 2.427m USD | 12M Return: 20.9% | BSP736841136 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 17.4M
EPS Trend: 98.4%
Qual. Beats: 0
Rev. Trend: 99.3%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 8.9 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
OneSpaWorld Holdings Limited (NASDAQ: OSW) is a health and wellness operator that primarily runs spas, fitness centers, and medi-spa facilities onboard cruise ships, with additional locations at destination resorts in the U.S. and internationally. Its service offering spans massage and body care, aesthetics, acupuncture, posture and gait analysis, and recovery therapies, alongside personalized fitness training, nutritional and weight management consultation, and an extensive menu of hydrotherapy amenities such as saunas, snow rooms, and salt crystal chambers. It also retails third-party brands including ELEMIS, Grown Alchemist, Kerastase, Thermage, Dysport, and Hyperice within its centers. The company was founded in 2017 and is headquartered in Nassau, Bahamas.
The company operates under a concession-based business model, staffing and managing wellness facilities on vessels and at resorts owned by its partners rather than owning the underlying real estate. This structure generally requires limited capital expenditure and ties its growth closely to global cruise deployment and onboard passenger spending on premium wellness services.
- Cruise fleet expansion lifts onboard wellness revenue
- Onboard spending per passenger grows on premium demand
- Operating margin expands from fixed cost leverage
| Net Income: 81.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.11 > 0.02 and ΔFCF/TA 1.60 > 1.0 |
| NWC/Revenue: 10.98% < 20% (prev 7.83%; Δ 3.15% < -1%) |
| CFO/TA 0.13 > 3% & CFO 95.5m > Net Income 81.0m |
| Net Debt (59.7m) to EBITDA (123.7m): 0.48 < 3 |
| Current Ratio: 2.91 > 1.5 & < 3 |
| Outstanding Shares: last quarter (102.4m) vs 12m ago -1.87% < -2% |
| Gross Margin: 14.29% > 18% (prev 15.91%; Δ -1.61% > 0.5%) |
| Asset Turnover: 138.1% > 50% (prev 125.6%; Δ 12.52% > 0%) |
| Interest Coverage Ratio: 6.81 > 6 (EBIT TTM 96.7m / Interest Expense TTM 14.2m) |
| A: 0.15 (Total Current Assets 169.1m - Total Current Liabilities 58.2m) / Total Assets 729.8m |
| B: -0.29 (Retained Earnings -208.7m / Total Assets 729.8m) |
| C: 0.13 (EBIT TTM 96.7m / Avg Total Assets 730.8m) |
| D: 3.94 (Book Value of Equity 582.2m / Total Liabilities 147.6m) |
| Altman-Z'' = 5.09 = AAA |
| DSRI: 1.03 (Receivables 53.6m/47.3m, Revenue 1.01b/919.3m) |
| GMI: 1.11 (GM 15.91% / 14.29%) |
| AQI: 0.96 (AQ_t 0.72 / AQ_t-1 0.75) |
| SGI: 1.10 (Revenue 1.01b / 919.3m) |
| TATA: -0.02 (NI 81.0m - CFO 95.5m) / TA 729.8m) |
| Beneish M = -2.85 (Cap -4..+1) = A |
As of October 17, 2026, the stock is trading at USD 23.85 with a total of 492,439 shares traded. Over the past week, the price has changed by +0.46%, over one month by +9.96%, over three months by -10.27% and over the past year by +20.86%.
Current recommended Stop Loss: 22.70 (which is 4.8% or 1.7 ATR below the current price).
OneSpaWorld Holdings has received a consensus analysts rating of 5.00. Therefore, it is recommended to buy OSW.
- StrongBuy: 6
- Buy: 0
- Hold: 0
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 31.2 | 30.8% |
P/E Trailing = 30.6538
P/E Forward = 27.8552
P/S = 2.4039
P/B = 3.879
Revenue TTM = 1.01b USD
EBIT TTM = 96.7m USD
EBITDA TTM = 123.7m USD
Long Term Debt = 81.6m USD (from longTermDebt, last quarter)
Short Term Debt = 1.53m USD (from shortTermDebt, last quarter)
Debt = 100.1m USD (from shortLongTermDebtTotal, last quarter) + Leases 9.25m
Net Debt = 59.7m USD (calculated: Debt 100.1m - CCE 40.4m)
Enterprise Value = 2.49b USD (2.43b + Debt 100.1m - CCE 40.4m)
Interest Coverage Ratio = 6.81 (Ebit TTM 96.7m / Interest Expense TTM 14.2m)
EV/FCF = 31.79x (Enterprise Value 2.49b / FCF TTM 78.2m)
FCF Yield = 3.15% (FCF TTM 78.2m / Enterprise Value 2.49b)
FCF Margin = 7.75% (FCF TTM 78.2m / Revenue TTM 1.01b)
Net Margin = 8.02% (Net Income TTM 81.0m / Revenue TTM 1.01b)
Gross Margin = 14.29% ((Revenue TTM 1.01b - Cost of Revenue TTM 865.2m) / Revenue TTM)
Gross Margin QoQ = 15.50% (prev 15.12%)
Tobins Q-Ratio = 3.41 (Enterprise Value 2.49b / Total Assets 729.8m)
Interest Expense / Debt = 14.17% (Interest Expense 14.2m / Debt 100.1m)
Taxrate = 4.57% (3.88m / 84.8m)
NOPAT = 92.3m (EBIT 96.7m * (1 - 4.57%))
Current Ratio = 2.91 (Total Current Assets 169.1m / Total Current Liabilities 58.2m)
Debt / Equity = 0.17 (Debt 100.1m / totalStockholderEquity, last quarter 582.2m)
Debt / EBITDA = 0.48 (Net Debt 59.7m / EBITDA 123.7m)
Debt / FCF = 0.76 (Net Debt 59.7m / FCF TTM 78.2m)
Total Stockholder Equity = 559.8m (last 4 quarters mean from totalStockholderEquity)
RoA = 11.08% (Net Income 81.0m / Total Assets 729.8m)
RoE = 14.46% (Net Income TTM 81.0m / Total Stockholder Equity 559.8m)
RoCE = 15.07% (EBIT 96.7m / Capital Employed (Equity 559.8m + L.T.Debt 81.6m))
RoIC = 14.58% (NOPAT 92.3m / Invested Capital 632.8m)
WACC = 9.54% (E(2.43b)/V(2.53b) * Re(9.38%) + D(100.1m)/V(2.53b) * Rd(14.17%) * (1-Tc(0.05)))
Discount Rate = 9.38% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -64.28 | Cagr: -0.23%
[DCF] Terminal Value 74.20% ; FCFF base≈73.6m ; Y1≈84.4m ; Y5≈124.2m
[DCF] Fair Price = 14.62 (EV 1.54b - Net Debt 59.7m = Equity 1.48b / Shares 101.5m; r=9.54% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 98.37 | EPS CAGR: 22.56% | SUE: 0.0 | # QB: 0
Revenue Correlation: 99.27 | Revenue CAGR: 9.87% | SUE: 0.17 | # QB: 0
EPS current Quarter (2026-09-30): EPS=0.30 | Chg30d=+0.00% | Revisions=-57% | Analysts=6
EPS current Year (2026-12-31): EPS=1.14 | Chg30d=+0.00% | Revisions=-17% | GrowthEPS=+14.8% | GrowthRev=+7.6%
EPS next Year (2027-12-31): EPS=1.29 | Chg30d=+0.00% | Revisions=-25% | GrowthEPS=+13.5% | GrowthRev=+8.7%
[Analyst] Revisions Ratio: -55% (up=1, down=7)